TABLE 1.

Summary of main clinical features of COVID‐19 patients on biologic therapies

Age	Sex	Disease	Ongoing treatment		COVID‐19
			Drug	Time	Clinic	Hospital admission	KT	Severity of disease
55	Woman	Palmoplantar psoriasis	Apremilast	6 mo	Bilateral pneumonia	3 d	Yes	Mild
42	Man	Psoriasis and psoriatic arthritis	Apremilast	12 mo	No symptoms (infected spouse)	Home confinement	Yes	None
55	Man	Psoriasis and psoriatic arthritis (leukemia)	Apremilast	6 mo	Bilateral pneumonia	ICU: 50 d	No	Severe
37	Man	Plaque psoriasis	Secukinumab	12 mo	Atypical bilateral pneumonia	9 d	No	Moderate
48	Woman	Psoriasis	Secukinumab	15 mo	Bilateral pneumonia	Home confinement	No	Mild
56	Man	Psoriatic arthritis	Infliximab	12 mo	Bilateral pneumonia	ICU: 15 d	No	Severe
52	Woman	Peripheral spondyloarthritis	Infliximab	3 y	Bilateral pneumonia	Home confinement: 12 d	No	Moderate

Abbreviations: COVID‐19, coronavirus disease 2019; ICU, intensive care unit; KT, keep treatment during COVID‐19 infection.